Broadfoot Jill Marie bought CUE
January 2, 2026 · Form 4 insider transaction
Broadfoot Jill Marie bought 24,400 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
24,400
Price
$0.00
Total value
N/A
InsiderBroadfoot Jill Marie
RoleDirector
CompanyCue Biopharma, Inc. (CUE)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after24,400
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.; This stock option becomes fully exercisable on the first anniversary of the grant date.